Send the following on WhatsApp
Continue to ChatComplex manufacturing, R&D, risks, losses — Bharat Biotech explains why Covaxin is expensive - ThePrint https://www.indiafinancenews.com/complex-manufacturing-rd-risks-losses-bharat-biotech-explains-why-covaxin-is-expensive-theprint/